Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
Lexaria Bioscience Corp. The company is headquartered in Kelowna, Canada.
52W High
$1.34
52W Low
$0.07
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.86
Valuation
As of 2025-05-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
N/A
Ownership
Source: Overview
Insiders (1–5% typical)
0.00%
Institutions (25–75% balanced)
0.00%
Shares Outstanding
0
Float
16,946,300
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-05-31 (Overview)
Revenue (TTM)
615,920
Gross Profit (TTM)
613,200
EPS (TTM)
N/A
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-21.55%
ROE (TTM) (>15% strong)
-1.53%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
1.07
Momentum
Bearish momentumValue
-0.0164
Previous
-0.0158
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025